SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-053713
Filing Date
2019-10-21
Accepted
2019-10-21 16:48:16
Documents
2
Period of Report
2019-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1696
2 POA DOCUMENT poa.txt EX-24.3_876567 3972
  Complete submission text file 0001209191-19-053713.txt   7090
Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
DAVIS A BRIAN (Reporting) CIK: 0001184432 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 191159948

Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations